| Jeevan Scientific Technology Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 538837 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE237B01018 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 30.97 |
Market Cap(₹Cr) : 105.55 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 10.43 | 8.22 | 8.92 | 11.87 | 10.30 | 12.52 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10.43 | 8.22 | 8.92 | 11.87 | 10.30 | 12.52 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.26 | 0.38 | 0.14 | 0.22 | 0.16 | 0.11 |
| Total Income | 10.69 | 8.59 | 9.07 | 12.08 | 10.46 | 12.63 |
| Total Expenditure | 8.96 | 9.33 | 9.83 | 9.83 | 8.36 | 9.13 |
| PBIDT | 1.73 | -0.73 | -0.77 | 2.26 | 2.11 | 3.50 |
| Interest | 0.38 | 0.36 | 0.35 | 0.26 | 0.27 | 0.15 |
| PBDT | 1.35 | -1.10 | -1.12 | 2.00 | 1.84 | 3.35 |
| Depreciation | 1.45 | 1.50 | 1.53 | 1.23 | 1.25 | 1.28 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.01 | -0.43 | -1.31 | 0.44 | 0.44 | 0.47 |
| Reported Profit After Tax | -0.09 | -2.16 | -1.34 | 0.32 | 0.15 | 1.60 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.09 | -2.16 | -1.34 | 0.32 | 0.15 | 1.60 |
| EPS (Unit Curr.) | -0.05 | -1.36 | -0.86 | 0.21 | 0.10 | 1.03 |
| EPS (Adj) (Unit Curr.) | -0.05 | -1.36 | -0.86 | 0.21 | 0.10 | 1.03 |
| Calculated EPS (Unit Curr.) | -0.05 | -1.36 | -0.84 | 0.20 | 0.10 | 1.03 |
| Calculated EPS (Adj) (Unit Curr.) | -0.05 | -1.36 | -0.84 | 0.20 | 0.10 | 1.03 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.22 | -5.46 | -3.38 | 0.81 | 0.39 | 4.14 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.22 | -5.46 | -3.38 | 0.81 | 0.39 | 4.14 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.83 | 15.83 | 15.83 | 15.83 | 15.48 | 15.48 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 16.59 | -8.88 | -8.63 | 19.04 | 20.49 | 27.96 |
| PBDTM(%) | 12.94 | -13.38 | -12.56 | 16.85 | 17.86 | 26.76 |
| PATM(%) | -0.86 | -26.28 | -15.02 | 2.70 | 1.46 | 12.78 |